Vice President, Head of Oncology Discovery and Early Development, AbbVie, Inc.
Thomas Hudson, M.D., is the Vice President, Head of Oncology Discovery and Early Development, and is based in Redwood City, California. Prior to his time at AbbVie, he was the President and Scientific Director of the Ontario Institute for Cancer Research, where he led the institute’s work in translational research for the prevention, detection, diagnosis and treatment of cancer. Internationally renowned for his work in genomics and human genome variation, his past positions include leadership roles as Founder and Director of the McGill University and Genome Quebec Innovation Centre and Assistant Director of the Whitehead/MIT Center for Genome Research. Dr. Hudson has served as a scientific advisor to many public organizations, including Genome England, the National Human Genome Research Institute (NIH) and the STARR Cancer Foundation.